Author
Morgan Adams FoundationORCID 0000-0002-9166-6961Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Elizabeth Janko, Faye M. Walker, Mathew Slade…·Nathan A. Dahl
This study evaluates ixazomib's efficacy against high-risk pediatric brain tumors, finding it cytotoxic but with limited CNS penetration.
Ilango Balakrishnan, Krishna P.C. Madhavan, Angela M. Pierce…·Sujatha Venkataraman
This paper identifies CD99 as a therapeutic target in K27M+DMGs, showing that a novel anti-CD99 antibody reduces tumor growth and enhances radiation efficacy in preclinical models.
Lays Martin Sobral, Faye M. Walker, Krishna P.C. Madhavan…·Nathan A. Dahl
This study identifies CDK9 as a conserved dependency in Myc-driven medulloblastoma and shows that CDK9 inhibition disrupts Myc-driven transcriptional programs, leading to anti-tumor effects.